HES1 and liver cancer: NPAS2 increases liver fibrosis in hepatocellular carcinoma by direct transcriptional activation of Hes1 in hepatic stellate cells and induces glucose metabolism reprogramming and cell survival by transactivating CDC25A in liver cancer cells.